Daniel S. Collins
Examiner (ID: 12325, Phone: (313)446-6535 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3745 |
Total Applications | 784 |
Issued Applications | 636 |
Pending Applications | 63 |
Abandoned Applications | 85 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16808353
[patent_doc_number] => 20210130906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => REPLICATION STRESS RESPONSE BIOMARKERS FOR IMMUNOTHERAPY RESPONSE
[patent_app_type] => utility
[patent_app_number] => 16/978758
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -113
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978758 | Replication stress response biomarkers for immunotherapy response | Mar 5, 2019 | Issued |
Array
(
[id] => 16614044
[patent_doc_number] => 20210032697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD FOR DISCRIMINATING SEX OF YELLOWTAIL GROUP
[patent_app_type] => utility
[patent_app_number] => 16/970697
[patent_app_country] => US
[patent_app_date] => 2019-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970697 | METHOD FOR DISCRIMINATING SEX OF YELLOWTAIL GROUP | Feb 17, 2019 | Pending |
Array
(
[id] => 16629037
[patent_doc_number] => 20210047690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHOD AND KIT FOR DETERMINING HYPEREXCITABILITY IN SUBJECT
[patent_app_type] => utility
[patent_app_number] => 16/968369
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968369 | Method and kit for determining hyperexcitability in subject | Feb 11, 2019 | Issued |
Array
(
[id] => 17163211
[patent_doc_number] => 11149300
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-10-19
[patent_title] => Methods of treating gastrointestinal malignancies
[patent_app_type] => utility
[patent_app_number] => 16/256840
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 22224
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16256840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/256840 | Methods of treating gastrointestinal malignancies | Jan 23, 2019 | Issued |
Array
(
[id] => 14306253
[patent_doc_number] => 20190142830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => C-RAF Mutants that Confer Resistance to RAF Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/255251
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/255251 | C-RAF Mutants that Confer Resistance to RAF Inhibitors | Jan 22, 2019 | Abandoned |
Array
(
[id] => 16391429
[patent_doc_number] => 20200332370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Methods for Quantification of Nucleosome Modifications and Mutations at Genomic Loci and Clinical Applications Thereof
[patent_app_type] => utility
[patent_app_number] => 16/960640
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960640 | Methods for Quantification of Nucleosome Modifications and Mutations at Genomic Loci and Clinical Applications Thereof | Jan 9, 2019 | Abandoned |
Array
(
[id] => 14868783
[patent_doc_number] => 20190284633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => DNA Methylation Diagnostic Test for Breast Cancer
[patent_app_type] => utility
[patent_app_number] => 16/235968
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235968 | DNA methylation diagnostic test for breast cancer | Dec 27, 2018 | Issued |
Array
(
[id] => 18469298
[patent_doc_number] => 20230203582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Method for Treatment of Hypertension
[patent_app_type] => utility
[patent_app_number] => 16/956215
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956215
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956215 | Method for Treatment of Hypertension | Dec 20, 2018 | Pending |
Array
(
[id] => 14278075
[patent_doc_number] => 20190136322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Method of Predicting Risk for Type 1 Diabetes
[patent_app_type] => utility
[patent_app_number] => 16/229699
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/229699 | Method of Predicting Risk for Type 1 Diabetes | Dec 20, 2018 | Abandoned |
Array
(
[id] => 16506559
[patent_doc_number] => 20200385815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => Using cfRNA for Diagnosing Minimal Residual Disease
[patent_app_type] => utility
[patent_app_number] => 16/768450
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768450 | Using cfRNA for Diagnosing Minimal Residual Disease | Dec 18, 2018 | Abandoned |
Array
(
[id] => 14471033
[patent_doc_number] => 20190187159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => TERMINAL ERYTHROID DIFFERENTIATION AS A BIOMARKER FOR PROGNOSIS AND TREATMENT, AND THERAPEUTIC TARGET IN MYELOID MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 16/223942
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223942 | Terminal erythroid differentiation as a biomarker for prognosis and treatment, and therapeutic target in myeloid malignancies | Dec 17, 2018 | Issued |
Array
(
[id] => 16073237
[patent_doc_number] => 20200190605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => DETECTIVE MOLECULE, KIT AND METHOD FOR PREDICTING FRAGRANCE PRODUCTION IN AN ORCHID
[patent_app_type] => utility
[patent_app_number] => 16/222373
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222373 | Detective molecule, kit and method for predicting fragrance production in an orchid | Dec 16, 2018 | Issued |
Array
(
[id] => 17953725
[patent_doc_number] => 11479819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Non-invasive method for monitoring transplanted organ status in organ-transplant recipients
[patent_app_type] => utility
[patent_app_number] => 16/772546
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5771
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 977
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772546 | Non-invasive method for monitoring transplanted organ status in organ-transplant recipients | Dec 13, 2018 | Issued |
Array
(
[id] => 14994483
[patent_doc_number] => 20190316199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => TEST METHOD FOR EVALUATING THE RISK OF ANTI-THYROID DRUG-INDUCED AGRANULOCYTOSIS, AND EVALUATION KIT
[patent_app_type] => utility
[patent_app_number] => 16/207650
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16207650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/207650 | TEST METHOD FOR EVALUATING THE RISK OF ANTI-THYROID DRUG-INDUCED AGRANULOCYTOSIS, AND EVALUATION KIT | Dec 2, 2018 | Abandoned |
Array
(
[id] => 17713715
[patent_doc_number] => 11377699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Methods for evaluating head and neck cancers
[patent_app_type] => utility
[patent_app_number] => 16/767090
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16131
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767090 | Methods for evaluating head and neck cancers | Nov 29, 2018 | Issued |
Array
(
[id] => 19339488
[patent_doc_number] => 12049669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Use of the IL-6 gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus
[patent_app_type] => utility
[patent_app_number] => 16/766371
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12791
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 964
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766371 | Use of the IL-6 gene expression level for classification of a subject in risk groups in the prognosis or diagnosis of type II diabetes mellitus | Nov 18, 2018 | Issued |
Array
(
[id] => 14439847
[patent_doc_number] => 20190177796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS FOR EVALUATING, MONITORING, AND MODULATING AGING PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/195674
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195674 | Methods for evaluating, monitoring, and modulating aging process | Nov 18, 2018 | Issued |
Array
(
[id] => 16452994
[patent_doc_number] => 20200362420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => NON-CODING RNA FOR DETECTION OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/763540
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763540 | NON-CODING RNA FOR DETECTION OF CANCER | Nov 8, 2018 | Abandoned |
Array
(
[id] => 17344039
[patent_doc_number] => 20220010370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR SEQUENCING POLYNUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/292400
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292400 | METHOD FOR SEQUENCING POLYNUCLEOTIDES | Nov 6, 2018 | Pending |
Array
(
[id] => 14044093
[patent_doc_number] => 20190078153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHOD OF ANALYZING GENETICALLY ABNORMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/183723
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16183723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/183723 | METHOD OF ANALYZING GENETICALLY ABNORMAL CELLS | Nov 6, 2018 | Abandoned |